1-6 of 6
Antonio Gualberto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations

Hye Won Lee, Jason K. Sa, Antonio Gualberto, Catherine Scholz, Hyun Hwan Sung, Byong Chang Jeong, Han Yong Choi, Ghee Young Kwon, Se Hoon Park
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (19): 5113–5119.
https://doi.org/10.1158/1078-0432.CCR-20-1246
Published: 01 October 2020
View article titled, A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring <em>HRAS</em> Mutations
Open the PDF for A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring <em>HRAS</em> Mutations in another window
Includes: Supplementary data
Journal Articles

Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition

Antonio Gualberto, Marisa Dolled-Filhart, Mark Gustavson, Jason Christiansen, Yu-Fen Wang, Mary L. Hixon, Jennifer Reynolds, Sandra McDonald, Agnes Ang, David L. Rimm, Corey J. Langer, Johnetta Blakely, Linda Garland, Luis G. Paz-Ares, Daniel D. Karp, Adrian V. Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (18): 4654–4665.
https://doi.org/10.1158/1078-0432.CCR-10-0089
Published: 14 September 2010
View article titled, Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition
Open the PDF for Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition in another window
Journal Articles

Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

Paul Haluska, Heather M. Shaw, Gretchen N. Batzel, Donghua Yin, Julian R. Molina, L. Rhoda Molife, Timothy A. Yap, M. Luisa Roberts, Amarnath Sharma, Antonio Gualberto, Alex A. Adjei, Johann S. de Bono
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5834–5840.
https://doi.org/10.1158/1078-0432.CCR-07-1118
Published: 01 October 2007
View article titled, Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
Open the PDF for Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors in another window
Journal Articles

Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor

Johann S. de Bono, Gerhardt Attard, Alex Adjei, Michael N. Pollak, Peter C. Fong, Paul Haluska, Luisa Roberts, Carrie Melvin, Madeline Repollet, David Chianese, Mark Connely, Leon W.M.M. Terstappen, Antonio Gualberto
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (12): 3611–3616.
https://doi.org/10.1158/1078-0432.CCR-07-0268
Published: 15 June 2007
View article titled, Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor
Open the PDF for Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor in another window
Journal Articles

Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays

Begoña Comin-Anduix, Antonio Gualberto, John A. Glaspy, Elisabeth Seja, Maribel Ontiveros, Deborah L. Reardon, Roberto Renteria, Brigitte Englahner, James S. Economou, Jesus Gomez-Navarro, Antoni Ribas
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (1): 107–116.
https://doi.org/10.1158/1078-0432.CCR-05-0136
Published: 05 January 2006
View article titled, Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays
Open the PDF for Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays in another window
Journal Articles

Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

Bruce D. Cohen, Deborah A. Baker, Catherine Soderstrom, George Tkalcevic, Ann Marie Rossi, Penny E. Miller, Mark W. Tengowski, Faye Wang, Antonio Gualberto, Jean S. Beebe, James D. Moyer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (5): 2063–2073.
https://doi.org/10.1158/1078-0432.CCR-04-1070
Published: 08 March 2005
View article titled, Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871
Open the PDF for Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871 in another window